<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Global Impact Ambassador]]></title><description><![CDATA[Global Impact Ambassador]]></description><link>https://www.global-impact-ambassadors.com/articles</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 12:03:50 GMT</lastBuildDate><atom:link href="https://www.global-impact-ambassadors.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Exciting Times Ahead for Global Impact Ambassadors in the Middle East]]></title><description><![CDATA[Arab News highlighted Saudi Arabia’s plans to announce major biotechnology and pharmaceutical partnerships during the Global Health Exhibition in Riyadh. The initiative forms part of the broader Vision 2030 transformation, a strategy that is rapidly reshaping the healthcare and life sciences landscape across the entire Middle East region. The royal families, the governments, investors, and healthcare leaders are accelerating efforts to strengthen health systems, expand pharmaceutical...]]></description><link>https://www.global-impact-ambassadors.com/post/exciting-times-ahead-for-global-impact-ambassadors-in-the-middle-east</link><guid isPermaLink="false">6a21d542513f7725cf1fa026</guid><pubDate>Thu, 04 Jun 2026 19:44:24 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a8098b_4c5a5adb33ef4a8cba5a54d732aaff17~mv2.png/v1/fit/w_1000,h_955,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Global Impact Ambassadors</dc:creator></item><item><title><![CDATA[The Shift Has Happened]]></title><description><![CDATA[Ethics Is Now a Condition for Doing Business Full article by the Times: https://www.thetimes.com/business/companies-markets/article/health-overtakes-climate-change-for-esg-investors-337j6kxb9?utm_source=chatgpt.com Global Impact Ambassadors: Over the past week, several developments across ESG and CSR, healthcare, and global markets have pointed to a shift that has been building for years, but is now becoming undeniable. Ethical business is no longer a positioning strategy. It is becoming a...]]></description><link>https://www.global-impact-ambassadors.com/post/the-shift-has-happened</link><guid isPermaLink="false">6a21d1fe513f7725cf1f9833</guid><pubDate>Thu, 04 Jun 2026 19:34:18 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a8098b_4b3196d66e9a42008a4ff66c0533ace3~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Global Impact Ambassadors</dc:creator></item><item><title><![CDATA[I have been advocating this since 2019, and actively implementing it since 2020.]]></title><description><![CDATA[Ethical business is not a marketing strategy.It is not a branding exercise.And it is certainly not a “nice to have” once profitability is secured. Recent commentary in the business press reinforces what should already be obvious: companies that treat ethics as infrastructure, rather than decoration, outperform over time. Culture, governance, transparency, and accountability are not soft concepts. They are risk management. They are brand protection. They are long-term value creation. Since...]]></description><link>https://www.global-impact-ambassadors.com/post/i-have-been-advocating-this-since-2019-and-actively-implementing-it-since-2020</link><guid isPermaLink="false">6a21cd5b1f44c606b3750a74</guid><pubDate>Thu, 04 Jun 2026 19:16:07 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a8098b_bc782ef523ff47ef9986a54b74ff641b~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Global Impact Ambassadors</dc:creator></item><item><title><![CDATA[When the Courts Step In, the Industry Must Listen.]]></title><description><![CDATA[The Supreme Court of India recently made a clear and important observation: patients and the public must have access to proper remedies when pharmaceutical companies engage in unethical practices. The Court questioned whether voluntary industry codes are sufficient and pointed to the need for stronger, enforceable mechanisms rather than merely signal good intent. This is not an anti-pharma argument. It is a pro-ethics, pro-patient, and pro-trust one. Unethical behaviour in our industry does...]]></description><link>https://www.global-impact-ambassadors.com/post/when-the-courts-step-in-the-industry-must-listen</link><guid isPermaLink="false">6a21cafc1f44c606b3750593</guid><pubDate>Thu, 04 Jun 2026 19:03:44 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a8098b_d48d409e0e994a5ab45738e3054ef610~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Global Impact Ambassadors</dc:creator></item></channel></rss>